Position history for BAKER BROS. ADVISORS LP's holdings in MADRIGAL PHARMACEUTICALS INC
BAKER BROS. ADVISORS LP holds 2.1M shares of MDGL (MADRIGAL PHARMACEUTICALS INC), worth $1.2B as of 2025-Q4. MDGL represents 7.3% of BAKER BROS. ADVISORS LP's portfolio.
Current Value
$1.2B
Current Shares
2.1M
Total Value Change
+$694M
Total Shares Change
+167,111
Other major holders of MDGL: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Unchanged |
| 2.1M |
0.0% |
| $1.2B |
| 7.3% |
| $583.73 |
0 |
| 2025-Q3 | Increased | 2.1M | +8.4% | $982.3M | 7.1% | $443.10 | 67 |
| 2025-Q2 | Increased | 2M | +0.1% | $598M | 5.8% | $300.75 | 61 |
| 2025-Q1 | Unchanged | 2M | 0.0% | $654M | 7.2% | $327.87 | 0 |
| 2024-Q4 | Unchanged | 2M | 0.0% | $609.3M | 6.5% | $311.62 | 0 |
| 2024-Q3 | Unchanged | 2M | 0.0% | $419M | 4.3% | $212.43 | 0 |
| 2024-Q2 | Increased | 2M | +0.2% | $553.2M | 7.1% | $280.16 | 61 |